SS&H Financial Advisors Inc. Purchases 372 Shares of Cigna Group $CI

SS&H Financial Advisors Inc. lifted its position in Cigna Group (NYSE:CI) by 25.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,832 shares of the health services provider’s stock after purchasing an additional 372 shares during the quarter. SS&H Financial Advisors Inc.’s holdings in Cigna Group were worth $606,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CI. Flaharty Asset Management LLC bought a new position in shares of Cigna Group in the first quarter worth $28,000. 1248 Management LLC bought a new position in shares of Cigna Group in the first quarter worth $29,000. Solstein Capital LLC bought a new position in shares of Cigna Group in the second quarter worth $29,000. Activest Wealth Management increased its holdings in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the period. Finally, Chilton Capital Management LLC bought a new position in shares of Cigna Group in the second quarter worth $30,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 1.0%

Shares of NYSE:CI opened at $244.67 on Friday. The stock’s 50-day moving average price is $297.19 and its 200-day moving average price is $305.96. Cigna Group has a 12-month low of $240.67 and a 12-month high of $350.00. The stock has a market capitalization of $65.31 billion, a P/E ratio of 13.36, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period last year, the firm earned $7.51 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Guggenheim decreased their price target on shares of Cigna Group from $350.00 to $309.00 in a report on Friday. The Goldman Sachs Group initiated coverage on Cigna Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $370.00 target price on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday, October 8th. Wells Fargo & Company increased their target price on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Finally, Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $350.74.

Insider Transactions at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by company insiders.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.